These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8595733)

  • 21. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 22. Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers?
    Peus D; Heit JA; Pittelkow MR
    J Am Acad Dermatol; 1997 Apr; 36(4):616-20. PubMed ID: 9092749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotyping and genotyping of coagulation factor V Leiden.
    Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
    Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
    Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
    Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid detection of 1717-1G----A mutation in CFTR gene by PCR-mediated site-directed mutagenesis.
    Cremonesi L; Seia M; Magnani C; Ferrari M
    Clin Chem; 1991 Nov; 37(11):1967. PubMed ID: 1718633
    [No Abstract]   [Full Text] [Related]  

  • 27. Testing for resistance to activated protein C factor V R506Q.
    Mack R; Albanese E; Fernandes H
    Arch Pathol Lab Med; 1998 Dec; 122(12):1046. PubMed ID: 9870848
    [No Abstract]   [Full Text] [Related]  

  • 28. Neonatal purpura fulminans in association with factor V R506Q mutation.
    Pipe SW; Schmaier AH; Nichols WC; Ginsburg D; Bozynski ME; Castle VP
    J Pediatr; 1996 May; 128(5 Pt 1):706-9. PubMed ID: 8627449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-linking hybridization assay for direct detection of factor V Leiden mutation.
    Zehnder J; Van Atta R; Jones C; Sussman H; Wood M
    Clin Chem; 1997 Sep; 43(9):1703-8. PubMed ID: 9299963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 31. Factor V Leiden detection by polymerase chain reaction-restriction fragment length polymorphism with mutagenic primers in a multiplex reaction with Pro G20210A--a novel technique.
    Welbourn JT; Maiti S; Paley J
    Hematology; 2003 Apr; 8(2):73-5. PubMed ID: 12745655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of 1078 delT mutation by PCR-mediated site-directed mutagenesis: detection of cystic fibrosis carriers in a celtic population.
    Dorval I; Fergelot P; Dubourg C; Jézéquel P; Chauvel B; Le Gall JY; Le Treut A
    Clin Chem; 1994 Dec; 40(12):2318-9. PubMed ID: 7527310
    [No Abstract]   [Full Text] [Related]  

  • 33. Real-time fluorescence genotyping of factor V Leiden during rapid-cycle PCR.
    Lay MJ; Wittwer CT
    Clin Chem; 1997 Dec; 43(12):2262-7. PubMed ID: 9439442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the minisequencing method for detection of G1691A (Leiden) factor V mutation.
    Łaczmański Ł; Ślęzak R; Karpiński P; Kolačkov K; Lebioda A; Milewicz A
    Gynecol Endocrinol; 2013 Apr; 29(4):319-22. PubMed ID: 23256575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
    Voorberg J; Roelse J; Koopman R; Büller H; Berends F; ten Cate JW; Mertens K; van Mourik JA
    Lancet; 1994 Jun; 343(8912):1535-6. PubMed ID: 7911872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations.
    Kodaira H; Ishida F; Shimodaira S; Takamiya O; Furihata K; Kitano K
    Acta Haematol; 1997; 98(1):22-5. PubMed ID: 9210909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterisation of Tyr530Ser and IVS16-1G>T mutations causing severe factor V deficiency.
    Zheng W; Liu Y; Luo Y; Chen Z; Wang Y; Zhang L; Gao G; Yao Z
    Thromb Haemost; 2010 Sep; 104(3):536-43. PubMed ID: 20664902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated protein C (APC)-resistance: automated detection of the point mutation at position 1691 in the factor V gene.
    Klingler KR; Grote S; Holzem G; Wielckens K
    Clin Chem Lab Med; 1999 Feb; 37(2):101-7. PubMed ID: 10219496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of alpha 1-antitrypsin Z and S mutations by polymerase chain reaction-mediated site-directed mutagenesis.
    Tazelaar JP; Friedman KJ; Kline RS; Guthrie ML; Farber RA
    Clin Chem; 1992 Aug; 38(8 Pt 1):1486-8. PubMed ID: 1643720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutations.
    Maher C; Crowley D; Cullen C; Wall C; Royston D; Fanning S
    Thromb Haemost; 1999 Jan; 81(1):76-80. PubMed ID: 9974379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.